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Introduction: Millions of patients undergo major abdominal surgery worldwide
each year, and the post-operative phase carries a high risk of respiratory and
circulatory complications. Standard ward observation of patients includes vital
sign registration at regular intervals. Patients may deteriorate between measure-
ments, and this may be detected by continuous monitoring. The aim of this
study was to compare the number of micro events detected by continuous
monitoring to those documented by the widely used standardized Early Warning
Score (EWS).
Methods: Fifty patients were continuously monitored with peripheral arterial oxy-
gen saturation (SpO2), heart rate (HR), and respiratory rate (RR) the first 4 days after
major abdominal cancer surgery. EWS was monitored as routine practice. Number
and duration of events were analyzed using Fisher’s exact test and Wilcoxon rank
sum test.
Results: Continuous monitoring detected a SpO2 <92% in 98% of patients vs 16%
of patients detected by EWS (P < .0001). Micro events of SpO2 <92% lasting longer
than 60 minutes were found in 58% of patients by continuous monitoring vs 16%
by the EWS (P < .0001). Fifty-two percent of patients had micro events of SpO2
<85% lasting longer than 10 minutes. Continuous monitoring found tachycardia in
60% of patients vs 6% by the EWS. Frequency of events for bradycardia, tachypnea,
and bradypnea showed similar patterns.
Conclusion: Very low SpO2 and tachycardia in post-operative patients are common
and under-diagnosed by the EWS. Continuous monitoring can discover these micro
events and potentially contribute to earlier detection and, potentially, result in pre-
vention of clinical complications.
1 | INTRODUCTION
Millions of patients undergo major abdominal surgical procedures
annually.1 Post-operative complication rates are between 15%-45%
depending on the surgical procedure,2,3 with prolonged in-hospital
stay and Intensive Care Unit admission aside from the eminent
discomfort and potential long-term disability. Among the most
frequent complications are pulmonary and circulatory complications
and it is estimated that 10 million patients experience myocardial
injury after noncardiac surgery (MINS) each year.4,5 Prevention or
early intervention of these complications would thus make a major
difference in morbidity and mortality after abdominal surgery and
cause economic savings.6–8 In an attempt to identify patients at
risk of complications, standardized protocols like the Early Warning
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Score (EWS) have been implemented in several European coun-
tries. In the EWS, patients’ vital signs (heart rate [HR], blood pres-
sure, respiratory rate [RR], temperature, oxygen saturation, oxygen
supplementation, and level of alertness) are monitored at pre-spe-
cified intervals starting at 12 hours and decreasing in case of
abnormal vital signs (also called micro events).9,10 During these
long hours without observation patients might deteriorate without
detection, as suggested by previous studies where 90% of cases
with desaturation <90% lasting longer than 60 minutes went
undetected by routine ward rounds. Continuous monitoring may
thus improve patient care by increasing the sensitivity and predic-
tive accuracy of the detected deteriorations as well as detecting
them sooner.11–13
The aim of this study was to compare the frequency of severe
changes in post-operative cardiopulmonary physiological variables in
patients monitored continuously as well as with the EWS following
major abdominal cancer surgery. We hypothesized that continuous
monitoring would detect severe micro events more frequently than
EWS.
2 | METHODS
Approval was sought, but waived by the regional ethics committee
as it was a purely observational study (protocol number 16038949).
However, the study was approved by the Danish Data Protection
Agency (2012-58-0004). The study was registered at www.ClinicalTri
als.gov (NCT03102619) before inclusion began. Written informed
consent was obtained from all participating patients.
2.1 | Patient inclusion
Fifty patients were enrolled between 23 March and 1 July 2017 at
Bispebjerg Hospital and Rigshospitalet in Copenhagen, Denmark.
Inclusion criteria were: age ≥65 years, elective major abdominal can-
cer surgery with an estimated duration >2 hours, and preoperative
sinus rhythm. Patients had to be eligible to receive optimized care
according to the regimes on the given ward. Patients were excluded
if they were unable to give informed consent or if they had a treat-
ment limitation (such as a do-not-resuscitate-order).
2.2 | Monitoring
Isansys Lifetouch, Isansys Lifecare, Oxforshire, United Kingdom and
Nonin WristOx 3150, Nonin Medical inc., Minnesota, USA were
used. Lifetouch is a wireless patch with 2 ECG electrodes placed
on the front left side of the thorax. The Lifetouch transmits infor-
mation about HR and RR derived from a single lead ECG and
sends this data via Bluetooth to a bedside gateway every minute
as an average of the past 60 seconds. Nonin WristOx 3150 is a
wearable pulse oximeter measuring peripheral arterial oxygen satu-
ration (SpO2) through standard digital measurement every second
and transfers data via Bluetooth to the gateway. Data from the
pulse oximeter included raw data of values per second and a calcu-
lated average per minute of at least 5 reliable measurements.
Alarms on all devices were switched off, screen light dimmed and
nurses were instructed to make their own measurements for the
EWS, following general practice, and not use the values from the
research devices.
When patients were fit for discharge to the ward from the Post
Anesthesia Care Unit (PACU) per the standardized discharge crite-
ria,14 research personnel connected patients to the measuring
devices. Patients were instructed not to disconnect unless they were
attending personal hygiene or had diagnostic imaging done and
these devices were to stay connected until discharge or for a maxi-
mum of 4 days. Thus, 50 patients had SpO2, HR, and RR measured
continuously for up to 4 days.
Nurses on the surgical ward observed and recorded the patients’
vital signs according to the EWS algorithm per the clinical stan-
dard.10 Furthermore, we collected information on pain medication
and epidural catheter.
Study personnel attended the participating patients at least once
a day to change batteries in the devices and encourage patient com-
pliance to reduce data loss.
2.3 | Data analysis
In the EWS algorithm, all measured values are converted to a score
from 0 to 3. The conversion into single parameter scores are pre-
sented in Table 1. The algorithm used in the Capital Region of
Denmark requires physician assessment at a single parameter score
of 3 or a cumulated score of 7. To find micro events, data from
the continuous monitoring as well as from the EWS were analyzed
using threshold values from the EWS algorithm giving a single
TABLE 1 Single parameter scores according to the Early Warning
Score
0 1 2 3
HR 51-90 41-50 or 91-110 111-130 <41 or >130
RR 12-20 9-11 21-24 <9 or >24
SpO2 >95% 94%-95% 92%-93% <92%
HR, heart rate in beats per minute; RR, respiratory rate in breaths per
minute; SpO2: peripheral arterial oxygen saturation.
Editorial comment
The Early Warning Score assesses vital signs intermittently.
This study on major surgery patients found severe post-
operative micro events for all measured parameters (SpO2,
HR, and RR) using continuous monitoring that were not
always detected by the Early Warning Score.
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parameter score of 3. The threshold values defining abnormal phys-
iological parameters (micro events) were as follows: Hypoxemia
was defined as SpO2 <92%, tachycardia as >130 beats per minute,
bradycardia as <41 beats per minute, tachypnea as >24 breaths per
minute and bradypnea as <9 breaths per minute. In addition, the
occurrence of severe hypoxemic episodes with SpO2 <85% and
80% were analyzed. All parameters from the two observation
methods (continuous vs EWS) were compared regarding total num-
ber of occurrences, and duration of the individual events. The EWS
provides an uncertain estimate of the duration of micro events
because of the long interval in between measurements. The dura-
tion of an abnormal micro event in EWS was estimated as follows:
The time between the observed abnormal value and the previous
normal value divided by 2, plus any consecutive time with abnormal
values, plus the time between the observed abnormal value and the
first subsequent normal value divided by 2, thus assuming that the
abnormal value started and ended midway between normal/abnor-
mal values.
Artifacts were defined as: SpO2: Any change larger than 4% per
second and all values less than 20% were considered artifacts.15 To
calculate a reliable mean, we required at least 45 measurements per
minute. All HR measurements <20 or >250 beats per minute and
RR measurements >60 per minute were interpreted as artifacts.
Missing data: SpO2 data were lost when the patient did not wear
the device, when the battery was discharged, when the Bluetooth
connection was lost, or if the bedside gateway was switched off.
Data from the Lifetouch device were lost when the patch was loose
or taken off.
In case of patients undergoing subsequent surgery or transfer to
the ICU, data collection was interrupted until the patient returned to
the ward.
2.4 | Statistical analysis
Data were presented as number of patients with events (%) or med-
ian and 5-95% range for duration of events. Mean differences are
presented with 95% confidence intervals. For the statistical analysis,
SAS version 9.4 (SAS Institute, Cary, NC, USA) was used. Association
between categorical and continuous data were analyzed with the
Fisher’s exact test and Wilcoxon rank sum test respectively, and we
considered P < .05 statistically significant.
3 | RESULTS
The study included 50 patients for a total of 156.5 patient days of
monitoring (on average 3.1 days per patient, Figure 1). Baseline
characteristics are described in Table 2. EWS measurements were
collected for all patients. A total of 693 EWS measurements were
made which gave an average measurement interval of 5 hours and
25 minutes.
3.1 | Arterial oxygen saturation
A total of 2529 hours of continuous SpO2 data were collected
before removal of artifacts. After artifact removal (3% of total SpO2
data), 2453 hours and 32 minutes remained. Average amount of
data per patient was 49.1 hours corresponding to 65.3% of the total
time (67.3% before removal of artifacts).
One or more episodes of desaturation <92% were found in 98%
of the patients with continuous monitoring (Table 3) as compared to
16% with EWS (P < .0001). The continuous monitoring found 109
events lasting longer than 60 minutes in 29 patients (58%). Median
F IGURE 1 Trial flowchart
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number of events lasting longer than 60 minutes per patient was 1
(5%-95% range 0-7 events). Median hypoxemic time per patient was
435.5 minutes (5%-95% range 16-1801 minutes).
The mean difference between hypoxemic time according to the
continuous monitoring and to the EWS was 626 minutes (95% CI
420-833 minutes). Five of the desaturation events caught by the
EWS was not found by the continuous monitoring, due to missing
data from these periods of time.
Figure 2 illustrates the distribution of desaturation (SpO2 < 92%)
on days after surgery as well as time of day. Desaturation occurred
mainly on the second and third post-operative day and the distribu-
tion of total hypoxemic time was as follows: 34.9% of total hypox-
emic time was between 00 and 08, 27.4% between 08 and 16, and
37.7% between 16 and 24.
Hypoxemia with SpO2 <85% was found in 88% of the patients
with continuous monitoring, whereas the EWS only detected SpO2
<85% in 2 patients (4%). Fifty-two percent of patients had at least
one episode of SpO2 <85% lasting more than 10 minutes. Mean dif-
ference in time with SpO2 <85% when monitored continuously vs
by the EWS was 43.6 minutes. The continuous monitoring found
that 56% of the patients desaturated to <80% at some point during
the study while the EWS only found this in 2% of patients
(P < .0001).
3.2 | Heart rate
The accumulated time of obtained continuous HR data was
3353 hours. After removal of artifacts (0.03% of recorded time),
3352 hours were available. Continuous HR and RR data were
obtained 89.2% of the total time and the average time per patient
after artifact removal was 67 hours and 5 minutes.
Sixty percent of the patients were found to be tachycardic at
some point during the study by the continuous monitoring, however,
tachycardia was only recorded in 6% of patients (P < .0001) by the
EWS. Continuous monitoring detected bradycardia in 20% of the
patients and 4% were bradycardic for more than 60 minutes. No
bradycardic episodes were reported by the EWS.
3.3 | Respiratory rate
Total monitored time for continuous RR was 3350 hours and no arti-
facts were found. Tachypnea was detected in 74% of the patients
by the continuous monitoring and median duration of tachypnea
was 8.0 minutes (5%-95% range 0-189 minutes). The EWS discov-
ered 10 events of tachypnea out of which one was at a time without
continuously monitoring switched on. In seven events of tachypnea
registered in the EWS, a normal respiration rate was recorded by the
continuous monitoring.
The continuous monitoring detected bradypnea in 64% of the
patients. The EWS found bradypnea in one patient (2%). This event
was not detected by the continuous monitoring. The median dura-
tion of bradypnea according to the EWS was 2.0 minutes (mean dif-
ference 40.6 minutes, 95% CI 12.1-69.2 minutes).
For all the measured parameters continuous monitoring found
events in more patients than the EWS. Also, differences in duration
of micro events for the individual patient were discovered. The EWS
monitoring estimate resulted in long durations due to the intervals
between measurements, but only in few patients, whereas
TABLE 2 Baseline characteristics
Parameter n = 50
Sex M:F 29:21
Age (y) 71 (65-81)
Weight (kg) 78 (55-100)
BMI (kg/m2) 26 (19-35)
ASA physical status score, No (%)
ASA I 4 (8.0%)
ASA II 23 (46%)
ASA III 23 (46%)
ASA IV 0 (0.0%)
Medical history
Previous smoker 20 (40%)
Current smoker 12 (24%)
Alcohol consumptiona 8 (16%)
Previous stroke or TIA 5 (10%)
Other neurological disease 4 (8.0%)
Paroxysmal atrial fibrillation 2 (4.0%)
Ischemic heart disease 2 (4.0%)
Other cardiovascular disease 7 (14%)
Chronic obstructive pulmonary disease 5 (10%)
Asthma 3 (6.0%)
Other pulmonary disease 2 (4.0%)
Diabetes mellitus 8 (16%)
Gastrointestinal disease 5 (10%)
Other previous cancer diagnosis 6 (10%)
Other disease 7 (14.0%)
Type of surgery, n (%)
Colonic or rectal resection 15 (30%)
Esophagectomy 5 (10%)
Gastrectomy 3 (6.0%)
Pancreatic resection 6 (12%)
Pancreaticoduodenectomy 7 (14%)
Liver resection 8 (16%)
Explorative laparotomy 6 (12%)
Epidural catheter 33 (66%)
Post-operative opioids 18 (36%)
Post-operative opioid consumption (mg) 40 (20-160)
BMI, body mass index; TIA, transient ischemic attack.
Values are number (percentage) or median (5%-95% range). Opioid con-
sumption is reported as intravenous morphine equivalents and only for
the receiving patients.
aAlcohol consumption of more than recommended by the Danish Health
Authority, which is 24 g/d for men or 12 g/d for women.
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continuous monitoring detected deteriorations of varying duration
and in many patients (Figure 3A-C).
4 | DISCUSSION
Our study found clinically and statistically significant discrepancies
between the EWS-recorded abnormal vital parameters and those
registered by continuous monitoring in patients after major
abdominal cancer surgery. Hypoxemic micro events of SpO2 <92%
were found in 98% of patients with continuous monitoring com-
pared to only 16% found by the EWS. These severe micro events
were often of considerable duration, and severe desaturations (SpO2
<85%) lasting more than 10 minutes occurred in more than half of
patients.
We were able to examine SpO2, HR, as well as RR continuously
for 4 days in high-risk patients. This provided us with a substantial
amount of data despite a limited sample size of 50 patients and
TABLE 3 Cardiopulmonary micro events after major abdominal cancer surgery
Continuous monitoring, n = 50
Conventional EWS
monitoring, n = 50 P-value Mean difference (95% CI)
SpO2 <92%
Number of patients
Any SpO2 <92% 49 (98%) 8 (16%) <.0001
SpO2 <92% more than 5% of time 34 (68%) 5 (10%) <.0001
SpO2 <92% more than 10% of time 28 (56%) 0 <.0001
SpO2 <92% more than 16.7% of time 15 (30%) 0 <.0001
SpO2 <92% more than 25% of time 10 (20%) 0 .0012
Duration (min) 436 (16-1801) 0 (0-340) 626 (420-833)
Micro events lasting longer than 60 minutes
Micro events per patient 1 (0-7) 0 (0-1) <.0001
Number of patients with event 29 (58%) 8 (16%) <.0001
SpO2 <85%
Number of patients 44 (88%) 2 (4.0%) <.0001
Duration (min) 32 (0-198) 0 (0-0) 43.6 (24.1-63.1)
Micro events lasting longer than 10 minutes
Micro events per patient 1 (0-5) 0 (0-0) <.0001
Number of patients with event 26 (52%) 2 (4.0%) <.0001
SpO2 <80%
Number of patients 28 (56%) 1 (2.0%) <.0001
Duration, min. 1.0 (0-19) 0 (0-0) 2.1 (2.2 to 6.4)
Micro events lasting longer than 10 minutes
Micro events per patient 0 (0-0) 0 (0-0) .55
Number of patients with event 2 (4.0%) 1 (2.0%) 1.00
Heart rate >130 beats per minute
Number of patients 30 (60%) 3 (6.0%) <.0001
Duration (min) 6.0 (0-136) 0 (0-158) 10.7 (22.1 to 43.6)
Heart rate <41
Number of patients 10 (20%) 0 (0.0%) .0009
Duration (min) 0 (0-20) 0 (0-0) 7.7 (2.0 to 17.5)
Respiratory rate >24 breaths per minute
Number of patients 37 (74%) 4 (8.0%) <.0001
Duration (min) 8.0 (0-189) 0 (0-864) 18.2 (83.8 to 47.3)
Respiratory rate <9
Number of patients 32 (64%) 1 (2.0%) <.0001
Duration (min) 2.0 (0-313) 0 (0-0) 40.6 (12.1-69.2)
Values are number (percentage) or median (5%-95% range). Duration of each event is calculated as average cumulative duration among all included
patients.
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allowed us to detect statistically and clinically significant differences
in detected micro events. A post-hoc power analysis confirms that
by including 50 patients, we had power for detecting the observed
difference in SpO2 < 92% of more than 95% with a level of signifi-
cance of 5% and at least a power of 80% for the remaining micro
events.
However, SpO2 data collection was only achieved for 65.3% of
time, and adverse episodes during the non-recorded periods may not
have been identified, which means that the current observations may
be lower than if we had had complete SpO2 data. Since we calculated
the hypoxemic time as percentage of the total observation time and
not the recorded time (assuming patients to be normoxic during the
missing data periods), our results represent minimum numbers. Miss-
ing SpO2 data are comparable to a recent study by Sun et al
16 in
which only 833 of 1339 measured patients had sufficient SpO2 data.
Technical difficulties (battery power, Bluetooth connection unavail-
able or bedside gateway switched off) were the main reasons for loss
of data, but patient compliance was also challenged, if patients had
delirium or felt physically restricted by the devices. Last, data were
also missing during mobilization and personal hygiene as part of rou-
tine accelerated care. Due to missing SpO2 data, five of the desatura-
tion micro events detected by the EWS were not found by the
continuous monitoring, however, continuous monitoring discovered
more than 3000 micro events not detected by the EWS.
Similar to our study, technological advances now allow for con-
tinuous monitoring of vital parameters with so-called wear-and-for-
get devices to assess the usability and compare them to
conventional measurements.17–19
Estimating the arterial oxygen saturation from pulse oximetry has
a number of limitations. Performance of the pulse oximeter (SpO2)
to reflect arterial oxygenation is subject to biological variability as
well as sensor variability.20 Sensor accuracy is primarily determined
by the wavelength of the LED in the sensor, which varies between
manufacturers. The Nonin WristOx in our study is FDA and CE
marked and calibrated. Biological variability is mostly pronounced
in situations with low peripheral perfusion (eg vascular contraction
from pain, low temperature, hypotension etc.) or movement of the
pulse oximeter,20 and in those situations, continuous monitoring may
report lower SpO2 than measurements with EWS, where the nurses
have the opportunity to fit the pulse oximeter to the highest possi-
ble recording of SpO2. Taenzer et al
19 found discrepancy between
nurse SpO2 recordings and electronic recordings, and nurse measure-
ments were on average 6.5% (95% CI 4.0%-9.0%) higher than elec-
tronic recordings. Another study found differences between
continuous monitoring and nurse recordings on the RR with both
fewer and more counts by nurses than detected electronically.18
High frequency of desaturation has previously been described
with continuous monitoring. Sun et al. investigated the incidence of
SpO2 <90% in unselected patients undergoing non-cardiac surgery in
the 48 hours following discharge from PACU, and found desatura-
tions for more than 16.7% of the observation time in 21% of
included patients.16 We found 30% of patients to have SpO2 <92%
more than 16.7% of the time. Our higher number may be related to
the higher-risk surgery and the different SpO2 threshold. Regarding
duration of events, Sun et al. found events of SpO2 <90% lasting
longer than 60 minutes in 37% of patients, whereas we found
events of SpO2 <92% with a duration of more than 60 minutes in
58% of patients. Similar to our results, Sun et al. found a lower
detection of desaturation by the nurses than by continuous monitor-
ing as only 5% of patients had any hypoxemia according to nursing
flow sheets. We found the same discrepancy for HR and RR, and
the lesser detection of these vital parameters with the EWS has not
been described previously.
Night time SpO2 was measured continuously by G€ogenur et al.,
21
and SpO2 <90% was detected in 90% of recorded patient nights and
more than 2400 episodes of hypoxemia were reported. However,
F IGURE 2 Percentage SpO2<92% out of total monitored time per day. POD, post-operative day; n, number of patients monitored that day;
blue color, desaturation at night time (00:00 to 08:00), red color, desaturation at day time (08:00 to 16:00); green color, desaturation at
evening time (16:00 to 24:00)
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the study did not report duration or total time of recorded hypox-
emia which is an important factor as long intervals of low SpO2 have
been suggested to be involved in the pathogenesis of several com-
mon post-operative complications.22
According to the EWS algorithm all SpO2 values <92% requires the
nurse to contact a physician.10 It is therefore of clinical significance that
this appears to occur in almost all post-operative patients in our study.
As this high occurrence of unreported hypoxemia has been described
in previous studies, the post-operative regimes on the wards include
supplementary oxygen. Patients included in our study often had nasal
catheter with oxygen; 96% had supplementary oxygen during the first
post-operative day, 76% during the second day, 58% during the third
day and 34% during the 4th day. However this evidently did not elimi-
nate the exposure to hypoxemia. Post-operative imbalance of oxygena-
tion (either hypoxemia or supplemental oxygen resulting in hyperoxia)
has been linked to several post-operative cerebral, pulmonary and car-
diac complications, and surgical site infections.21,23–25 However, our
study was not powered to detect differences in clinical outcomes, but
these must be considered in future larger trials to substantiate the
effect of continuous monitoring and advocate for the initial increased
expenses and continued research.17
The EWS is commonly used in European countries for post-
operative observation and is connected to an escalation protocol for
more intensive measurements and potentially a rapid response team,
if vital parameters are affected.10,26 However, this study raises
important questions regarding the sensitivity of this method, because
the escalation protocol may not be activated if monitoring is not
performed continuously.27 Although differences in results for HR
and RR were not as prominent as for SpO2, most findings were sta-
tistically significant in terms of more sensitive detection of events
with continuous monitoring. This emphasizes that patients’ vital signs
vary in the days following major surgery, and that one normal mea-
surement in the morning does not necessarily reflect normal values
for the remaining day. Continuous detection of micro events may
lead to the de novo identification of new types of vital sign aberra-
tions, and this may in turn modify thresholds for clinical interven-
tions or indicate novel treatment pathways with the potential to be
more effective in keeping improvements in vital signs stable.
With continuous monitoring, we found 64% of patients to be
bradypneic (RR <9 breaths per minute) at some point during the first
four post-operative days, while the EWS only found this in 2%.
Patients are often awake and interacting with the nurses during the
EWS measurement. This may partly explain why the EWS rarely
finds bradypnea, as the RR is often reduced during sleep. However,
we did not analyze whether bradypnea was mainly found during
sleep or the relation to desaturation.
F IGURE 3 Duration of measured micro events in minutes per
patient according to continuous monitoring and EWS, respectively.
A: Duration of SpO2 <92%, B: Duration of tachycardia (HR
>130 bpm), C: Duration of tachypnea (RR >24 bpm). SpO2, arterial
oxygen saturation; EWS, Early Warning Score
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Seven episodes of tachypnea (RR >24 breaths per minute) were
registered by the EWS at times where the continuous monitoring
did not find tachypnea. This may be due to the difference in the
measuring methods as the continuous patch monitoring analyses
changes in the amplitude of the R peak in the ECG, whereas the
nurses count the number of breaths manually for the EWS.26 Most
reliable method is yet to be determined, and as previously stated a
discrepancy has earlier been observed between these two methods
as Weenk et al18 found both higher and lower counts of RR by con-
tinuous monitoring compared to standard measuring.
An advantage of the EWS is the contact between the nurse and
the patient, which is an opportunity for the nurse to observe the
patient clinically. However, this physical contact also has its disad-
vantages since nurses have to wake up patients late at night or early
in the morning to perform measurements. This may result in situa-
tions where the reported vital signs in the EWS do not reflect physi-
ology during night time. We collected several examples of patients
with low SpO2 in the minutes before EWS measurement which sub-
sequently turned normal or near-to-normal for a few minutes where
after it returned to lower levels. Thus, the EWS potentially reflects
the physiological capacity rather than the actual status and function.
The EWS hereby provides false security for nurses and physicians
who might not notice the deterioration of the patient. This potential
problem could be diminished with continuous monitoring. In one
extreme case, a patient was hypoxemic 72.7% of the time and the
desaturation of this patient was not at any time discovered by the
EWS. Severely low SpO2 may inflict organ damage such as in the
brain and heart. Our study thus indicates that continuous monitoring
theoretically can be beneficial to post-operative organ function, but
the exact threshold for hypoxia-induced organ damage is not yet
established.
5 | CONCLUSION
We found significantly more severe micro events of all measured
parameters (SpO2, HR, and RR) using continuous monitoring than
reported by the EWS. Prolonged hypoxemia of potential clinical
importance was common in this high-risk patient group the days fol-
lowing major abdominal cancer surgery and severe long-lasting
hypoxemic episodes were seen in more than half of patients. Future
studies must evaluate the clinical effect of continuous monitoring
compared to standardized interval based observation and interven-
tion in terms of the thresholds and durations of vital sign aberrations
that are most predictive of adverse outcome as well as the clinical
interventions that are most likely to make a positive difference.
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